Publicly Listed MEI Pharma Completes $100 Million Private Placement to Build Litecoin Strategic Reserves

Odaily Planet Daily News: MEI Pharma announced the completion of a $100 million private placement, selling 29,239,767 shares of common stock or equivalent prepaid warrants at a price of $3.42 per share. The proceeds will be used to establish a Litecoin strategic reserve.
The company has also appointed Charlie Lee, founder of Litecoin and lead investor in this private placement, to its board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the execution of the Litecoin reserve strategy. (businesswire)